Page last updated: 2024-09-05

sch 58261 and zm 241385

sch 58261 has been researched along with zm 241385 in 12 studies

Compound Research Comparison

Studies
(sch 58261)
Trials
(sch 58261)
Recent Studies (post-2010)
(sch 58261)
Studies
(zm 241385)
Trials
(zm 241385)
Recent Studies (post-2010) (zm 241385)
460144013124

Protein Interaction Comparison

ProteinTaxonomysch 58261 (IC50)zm 241385 (IC50)
Adenosine receptor A3Rattus norvegicus (Norway rat)0.0949
Adenosine receptor A2aHomo sapiens (human)0.0216
Adenosine receptor A2bHomo sapiens (human)0.0646

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (16.67)18.2507
2000's7 (58.33)29.6817
2010's2 (16.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Daly, JW; Jacobson, KA; Melman, N; Padgett, WL; Shi, D; Siddiqi, SM; van Rhee, AM1
Dionisotti, S; Fredholm, BB; Gessi, S; Irenius, E; Ongini, E1
Beukers, MW; Brouwer, J; den Dulk, H; Ijzerman, AP; van Tilburg, EW1
Guba, W; Nettekoven, M; Püllmann, B; Riemer, C; Schmitt, S1
Chen, L; Engber, T; Grant, D; Hetu, G; Huang, C; Jin, X; Kumaravel, G; Peng, B; Petter, RC; Phadke, D; Reilly, J; Smits, G; Tam, S; Vu, CB; Zhang, J1
Engber, T; Grant, D; Hetu, G; Huang, C; Jin, X; Kumaravel, G; Pan, D; Peng, B; Petter, RC; Phadke, D; Reilly, J; Smits, G; Tam, S; Vu, CB1
Ayyub, E; Chang, HX; Dowling, JE; Engber, T; Haque, S; Jin, X; Kumaravel, G; Petter, RC; Phadke, D; van Vloten, K; Vessels, JT; Wang, J1
Gao, ZG; Jacobson, KA1
Beukers, MW; Brussee, J; de Graaf, O; de Vries, H; Göblyös, A; Ijzerman, AP; Link, R; Mantri, M; Mulder-Krieger, T; van Veldhoven, J; von Frijtag Drabbe Künzel, JK1
Federico, S; Jacobson, KA; Jayasekara, PS; Kozma, E; Moro, S; Paoletta, S; Spalluto, G; Squarcialupi, L1
de Lera Ruiz, M; Lim, YH; Zheng, J1
Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G1

Reviews

4 review(s) available for sch 58261 and zm 241385

ArticleYear
Adenosine receptors as therapeutic targets.
    Nature reviews. Drug discovery, 2006, Volume: 5, Issue:3

    Topics: Animals; Disease; Drug Therapy; Humans; Ligands; Molecular Structure; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Structure-Activity Relationship

2006
Fluorescent ligands for adenosine receptors.
    Bioorganic & medicinal chemistry letters, 2013, Jan-01, Volume: 23, Issue:1

    Topics: Boron Compounds; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Ligands; Protein Binding; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1

2013
Adenosine A2A receptor as a drug discovery target.
    Journal of medicinal chemistry, 2014, May-08, Volume: 57, Issue:9

    Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction

2014
Adenosine receptor antagonists: Recent advances and therapeutic perspective.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship

2022

Other Studies

8 other study(ies) available for sch 58261 and zm 241385

ArticleYear
Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists.
    Journal of medicinal chemistry, 1996, Jan-19, Volume: 39, Issue:2

    Topics: Animals; Binding Sites; Humans; Male; Mice; Models, Molecular; Motor Activity; Purinergic P1 Receptor Antagonists; Rats; Structure-Activity Relationship; Thiophenes

1996
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 1999, Volume: 359, Issue:1

    Topics: Animals; Cell Line; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Rats; Transfection; Triazines; Triazoles; Xanthines

1999
Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine.
    Molecular pharmacology, 2000, Volume: 58, Issue:6

    Topics: Adenosine; Alkynes; Amino Acid Sequence; Animals; Asparagine; COS Cells; Cyclic AMP; Molecular Sequence Data; Mutation; Point Mutation; Protein Conformation; Purinergic P1 Receptor Agonists; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; Sequence Homology, Amino Acid; Transfection; Tyrosine

2000
Comparison of inhibitory activity of isomeric triazolopyridine derivatives towards adenosine receptor subtypes or do similar structures reveal similar bioactivities?
    Bioorganic & medicinal chemistry letters, 2004, Jun-21, Volume: 14, Issue:12

    Topics: Binding Sites; Humans; Purinergic P1 Receptor Antagonists; Pyridines; Receptors, Purinergic P1; Structure-Activity Relationship; Triazoles

2004
Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
    Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17

    Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Animals; Antiparkinson Agents; Biological Availability; Brain; Catalepsy; Heterocyclic Compounds, 2-Ring; In Vitro Techniques; Male; Mice; Parkinsonian Disorders; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Structure-Activity Relationship; Triazines; Triazoles

2004
Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
    Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6

    Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Animals; Antiparkinson Agents; Binding, Competitive; Biological Availability; Catalepsy; Cerebral Cortex; Combinatorial Chemistry Techniques; Diamines; In Vitro Techniques; Male; Mice; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Stereoisomerism; Triazines; Triazoles

2005
Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists.
    Bioorganic & medicinal chemistry letters, 2005, Nov-01, Volume: 15, Issue:21

    Topics: Adenosine A2 Receptor Antagonists; Animals; Brain; Cell Membrane; Disease Models, Animal; Parkinson Disease; Pyrazines; Radioligand Assay; Rats; Structure-Activity Relationship

2005
2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
    Journal of medicinal chemistry, 2008, Aug-14, Volume: 51, Issue:15

    Topics: Adenosine A2 Receptor Antagonists; Amines; Animals; Cell Line; Cricetinae; Cyclic AMP; Furans; Humans; Models, Molecular; Molecular Structure; Nicotinic Acids; Nitriles; Receptor, Adenosine A2A; Structure-Activity Relationship

2008